James F. Reddoch

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Sean Weisberg, as Attorney-in-Fact for James F. Reddoch
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for James F. Reddoch

Form 4 holding EVP & Chief Scientific Officer

Royalty Pharma plc

Security class
Class A Ordinary Shares
Shares / value
820,800
Estimated value
$22,611,070
Report date
28 Sep 2022
Price
$27.55
Ownership
By Reddoch RPI LLC
Form 4 holding EVP & Chief Scientific Officer

Royalty Pharma plc

Security class
Class A Ordinary Shares
Shares / value
25,030
Estimated value
$689,516
Report date
28 Sep 2022
Price
$27.55
Ownership
By IRA
Form 4 holding EVP & Chief Scientific Officer

Royalty Pharma plc

Security class
LP interests in RPI US Partners 2019, LP
Shares / value
478,870
Estimated value
Report date
12 Aug 2022
Price
Ownership
By Reddoch RPI LLC
Underlying class
Class A Ordinary Shares
Underlying amount

Insider Reports Filed by James F. Reddoch

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .